Related Experiment Videos
[Carbocysteine in the treatment of recurrent bronchitis in infants]
P Bánovcin1, L Jakusová, V Rösslerová
1Detská klinika Jeseniovej lekárskej fakulty Univerzity Komenského, Martin.
Insights
Carbocysteine demonstrated superior therapeutic effectiveness compared to Ipeca syrup for treating acute relapsing bronchitis in infants. This study highlights carbocysteine as a more favorable option for pediatric respiratory infections.
Area of Science:
- Pediatric Pulmonology
- Pharmacology
- Clinical Medicine
Context:
- Acute relapsing bronchitis is a common respiratory illness in infants.
- Evaluating effective mucolytic agents is crucial for managing pediatric respiratory conditions.
- Previous treatments have shown variable efficacy in infant populations.
Purpose:
- To compare the therapeutic effectiveness of carbocysteine with Ipeca syrup in infants with acute relapsing bronchitis.
- To assess the clinical and laboratory outcomes of carbocysteine treatment.
- To determine the optimal mucolytic agent for this pediatric demographic.
Summary:
- A study involving 51 children aged 6-24 months evaluated carbocysteine versus Ipeca syrup for acute relapsing bronchitis.
- Effectiveness was measured using a point score system, including clinical changes and laboratory data.
- Carbocysteine showed a more favorable therapeutic effect than Ipeca syrup in treating this condition.
Impact:
- Provides evidence supporting carbocysteine as a preferred mucolytic agent for infant acute relapsing bronchitis.
- Informs clinical practice guidelines for managing pediatric respiratory infections.
- Suggests potential for improved patient outcomes and reduced treatment duration in infants.
Abstract:
In a group of 51 children aged 6-24 months the therapeutic effectiveness of the mucolytic preparation carbocysteine was tested and compared with the effect of Ipeca syrup. The effect was evaluated by means of a point score comprising changes of the clinical picture of the disease and the use of other laboratory examinations. The results of the examination revealed the more favourable effect of carbocysteine, as compared with a mixture of Ipeca syrup in the treatment of acute relapsing bronchitis in infants.